Form 4 Tracker
Kymera Therapeutics, Inc.
KYMR

46 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 23, 2025May 23 8:20 PMChadwick Jeremy G
Proposed Sale
2,575$30.17$77.7K

View →

Mar 3, 2025Mar 3 11:00 PMChadwick Jeremy G
Proposed Sale
1,383$31.35$43.4K

View →

Mar 3, 2025Mar 3 11:00 PMChiniara Ellen
Proposed Sale
2,241$31.35$70.3K

View →

Mar 3, 2025Mar 3 11:00 PMGollob Jared
Proposed Sale
5,740$31.35$179.9K

View →

Mar 3, 2025Mar 3 11:00 PMJacobs Bruce N.
Proposed Sale
7,035$31.35$220.5K

View →

Jan 6, 2025Jan 6 9:30 PMChiniara Ellen
Proposed Sale
3,129$41.59$130.1K

View →

Dec 2, 2024Dec 2 9:41 PMPAMELA ESPOSITO
Proposed Sale
2,500$46.85$117.1K

View →

Sep 17, 2024Sep 17 8:40 PMPAMELA ESPOSITO
Proposed Sale
13,500$48.48$654.5K

View →

Aug 26, 2024Aug 26 8:32 PMJOANNA HOROBIN
Proposed Sale
12,000$49.16$589.9K

View →

Aug 26, 2024Aug 26 8:25 PMJEFFREY ALBERS
Proposed Sale
5,000$47.78$238.9K

View →

← Previous

Page 7 of 7

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Option Exercise
5,500$49.105,000(D)

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08275,559(D)

View →

← Previous

Page 3 of 3